Previous 10 | Next 10 |
SAN CARLOS, Calif. , May 13, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at the UBS Virtual Global Healthcare Conference on Monday, May 18, 2020 ...
Natera (NASDAQ: NTRA ) reports that it has settled its patent infringement litigation with Illumina (NASDAQ: ILMN ) related to non-invasive prenatal testing (NIPT) and pre-implantation genetic screening and diagnosis activities. More news on: Natera, Inc., Illumina, Inc., Healthcare stoc...
SAN CARLOS, Calif. , May 11, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Noridian, a Medicare Administrative Contractor (MAC), has issued positive coverage for the Prospera donor-derived cell-free DNA ...
Natera, Inc. (NTRA) Q1 2020 Earnings Conference Call May 6, 2020 4:30 P.M. ET Company Participants Michael Brophy - Chief Financial Officer Steve Chapman - Chief Executive Officer Solomon Moshkevich - General Manager, Oncology and Transplant Conference Call Participants Dou...
Image source: The Motley Fool. Natera (NASDAQ: NTRA) Q1 2020 Earnings Call May 06, 2020 , 4:30 p.m. ET Operator Continue reading
ION Geophysical (NYSE: IO ) +87% on Q1 results . More news on: ION Geophysical Corporation, Tetraphase Pharmaceuticals, Inc., Fastly, Inc., Stocks on the move, , Read more ...
The following slide deck was published by Natera, Inc. in conjunction with their 2020 Q1 earnings Read more ...
Natera (NASDAQ: NTRA ): Q1 GAAP EPS of -$0.45 beats by $0.12 . More news on: Natera, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SAN CARLOS, Calif. , May 6, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the first quarter ended March 31, 2020 and provided an update on recent business progress. Recent...
SAN CARLOS, Calif. , May 4, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the achievement of key recruitment milestones in the ProActive registry study and success in the Prospera early access program....
News, Short Squeeze, Breakout and More Instantly...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2024, after the market close on Aug. 8, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...